TEKTURNA Side Effects

6220861-3 | Anaemia, Anxiety, Blood Pressure Decreased, Metastases To Central Nervous System, Vertigo Positional
on Jun 01, 2009 Male patient from UNITED STATES , weighting 168.0 lb, was diagnosed with hypertension, neoplasm malignant, depression (What is depression?) and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anxiety (What is anxiety?), blood pressure decreased, metastases to central nervous system, vertigo positional. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with CISPLATIN (Once Weekly For 2 Cycles) (View Cisplatin Review and Cisplatin Label ), ETOPOPHOS PRESERVATIVE FREE (Daily For One Week, 2 Cycles) (View Etopophos Preservative Free Review and Etopophos Preservative Free Label ), AMLODIPINE (10 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), LEXAPRO (10 Mg, Unk) (View Lexapro Review and Lexapro Label ).

6219614-1 | Vision Blurred
Patient was taking Tekturna (View Usage). Patient had the following side effects: vision blurred on Jun 02, 2009 from UNITED STATES Additional patient health information: Male patient , 87 years of age, . Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with MICARDIS (Unk, Unk) (View Micardis Review and Micardis Label ), TOPROL XL (Unk, Unk) (View Toprol-xl Review and Toprol-xl Label ).

6210332-2 | Blood Pressure Increased, Cardiac Disorder, Joint Swelling, Oedema Peripheral, Swelling Face
Adverse event was reported on May 20, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 255.2 lb, After Tekturna was administered, patient had the following side effects: blood pressure increased, cardiac disorder, joint swelling, oedema peripheral, swelling face. During the same period patient was treated with ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), ANTIDEPRESSANTS (Unk, Unk) (View Antidepressants Review and Antidepressants Label ), LITHIUM CARBONATE (300 Mg Qam, 450 Mg Qpm) (View Lithium Carbonate Review and Lithium Carbonate Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), AMBIEN (10 Mg, Qhs) (View Ambien Review and Ambien Label ), PERPHENAZINE (12 Mg, Qhs) (View Perphenazine Review and Perphenazine Label ).

6196243-X | Confusional State, Disorientation, Dizziness, Electroencephalogram Abnormal, Epilepsy, Headache
on May 14, 2009 Female patient from UNITED STATES , weighting 152.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disorientation, dizziness (What is dizziness?), electroencephalogram abnormal, epilepsy (What is epilepsy?), headache (What is headache?). Tekturna dosage: 300 Mg Daily. During the same period patient was treated with DIOVAN HCT (320/25mg Daily) (View Diovan Hct Review and Diovan Hct Label ), NADOLOL (40 Mg, Qd) (View Nadolol Review and Nadolol Label ), SYNTHROID (50 Ug, Qd) (View Synthroid Review and Synthroid Label ), NORVASC (2.5 Mg, Qd) (View Norvasc Review and Norvasc Label ), LOVAZA (View Lovaza Review and Lovaza Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ).


6194018-9 |
on May 15, 2009 Female patient from UNITED STATES , 42 years of age, weighting 250.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). . Tekturna dosage: 150 Mg, Once/single. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), NORVASC (View Norvasc Review and Norvasc Label ), COREG (40 Mg, Unk) (View Coreg Review and Coreg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6184134-X | Blood Pressure Diastolic Increased, Headache
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood pressure diastolic increased, headache (What is headache?) on May 05, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 133.0 lb, was diagnosed with hypertension, essential hypertension and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CHONDROITIN SULFATE (View Chondroitin Sulfate Review and Chondroitin Sulfate Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ).

6182611-9 | Blood Sodium Decreased, Mental Status Changes
Adverse event was reported on Apr 30, 2009 by a Male patient taking Tekturna (View Usage) (Dosage: 150 Mg Daily) was diagnosed with hypertension and. Location: UNITED STATES , 40 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: blood sodium decreased, mental status changes. During the same period patient was treated with LISINOPRIL (40 Mg, Unk) (View Lisinopril Review and Lisinopril Label ), DYAZIDE (37.5 Mg, Unk) (View Dyazide Review and Dyazide Label ). Patient was hospitalized.

6176520-9 | Balance Disorder, Fall
on Apr 28, 2009 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: balance disorder, fall (What is fall?). Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with METOPROLOL TARTRATE (50 Mg, Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (20 Mg, Unk) (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (50 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (5 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), ZOCOR (40 Mg, Unk) (View Zocor Review and Zocor Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ).

6161115-3 | Vision Blurred
on Apr 17, 2009 Female patient from UNITED STATES , 65 years of age, weighting 144.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: vision blurred. Tekturna dosage: 1 Tab Every Day.

6160908-6 | Arthralgia, Contusion, Dizziness, Fall, Haematoma, Loss Of Consciousness, Musculoskeletal Stiffness, Tendon Injury
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, contusion, dizziness (What is dizziness?), fall (What is fall?), haematoma, loss of consciousness, musculoskeletal stiffness, tendon injury on Apr 17, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 154.0 lb, was diagnosed with hypertension and. Tekturna dosage: 150 Mg Once Daily Po 2 And Half Weeks.

6154024-7 |
Adverse event was reported on Apr 10, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 300 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 135.8 lb, . During the same period patient was treated with CARDURA /IRE/ (7 Mg, Bid) (View Cardura /ire/ Review and Cardura /ire/ Label ), ZYRTEC (10 Mg, Bid) (View Zyrtec Review and Zyrtec Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ISORDIL (20 Mg, Tid) (View Isordil Review and Isordil Label ), CLONIDINE (.02 Mg, Tid) (View Clonidine Review and Clonidine Label ), COREG (12.5 Mg, Bid) (View Coreg Review and Coreg Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ).

6152024-4 | Hypersensitivity
on Mar 31, 2009 Female patient from UNITED STATES , 70 years of age, was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: hypersensitivity. Tekturna dosage: 150 Mg (cut The 300 Mg Tablet Into Half).

6150463-9 | Cerebrovascular Accident, Headache, Hypertension
on Apr 07, 2009 Male patient from UNITED STATES , weighting 205.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, headache (What is headache?), hypertension. Tekturna dosage: 300/25 Mg, Daily. During the same period patient was treated with CLONIDINE (0.2 Mg, Tid) (View Clonidine Review and Clonidine Label ), LASIX (80 Mg, Bid) (View Lasix Review and Lasix Label ), LOPRESSOR (100 Mg, Bid) (View Lopressor Review and Lopressor Label ), NOVOLIN N (30 Unit Qam, 15 Units Qpm) (View Novolin N Review and Novolin N Label ), NOVOLIN R (Sliding Scale) (View Novolin R Review and Novolin R Label ), XANAX (Unk, Prn) (View Xanax Review and Xanax Label ), RESTORIL (30 Mg, Qhs) (View Restoril Review and Restoril Label ), LORA TAB (5/325 Mg, Prn) (View Lora Tab Review and Lora Tab Label ). Patient was hospitalized.

6150453-6 | Asthenia, Blood Pressure Fluctuation, Dry Mouth, Fatigue, Heart Rate Decreased, Knee Arthroplasty
Patient was taking Tekturna (View Usage). Patient had the following side effects: asthenia, blood pressure fluctuation, dry mouth, fatigue, heart rate decreased, knee arthroplasty on Mar 30, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with TERAZOSIN HCL (2 Mg, Qd) (View Terazosin Hcl Review and Terazosin Hcl Label ), WARFARIN SODIUM (Unk, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), PRILOSEC (Unk, Unk) (View Prilosec Review and Prilosec Label ), LORAZEPAM (0.5 Mg, Unk) (View Lorazepam Review and Lorazepam Label ).

6145596-7 |
Adverse event was reported on Apr 03, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 300 Mg, Unk) was diagnosed with hypertension and. Location: UNITED STATES , weighting 139.0 lb, . During the same period patient was treated with CARDURA /IRE/ (View Cardura /ire/ Review and Cardura /ire/ Label ), ZYRTEC (10 Mg, Bid) (View Zyrtec Review and Zyrtec Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ISOSORBIDE (20 Mg, Tid) (View Isosorbide Review and Isosorbide Label ), CLONIDINE (.02 Mg, Tid) (View Clonidine Review and Clonidine Label ), COREG (12.5 Mg, Bid) (View Coreg Review and Coreg Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ).

6143766-5 | Oedema Peripheral
on Mar 20, 2009 Female patient from UNITED STATES , 65 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ).

6140798-8 | Hypertensive Crisis
on Feb 19, 2008 Female patient from UNITED STATES , weighting 152.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: hypertensive crisis. Tekturna dosage: 300 Mg, Qd.

6139880-0 | Blood Pressure Increased
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood pressure increased on Mar 31, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 161.0 lb, was diagnosed with hypertension and. Tekturna dosage: 1 Tab Daily Oral. During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), ISRODIL (View Isrodil Review and Isrodil Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLETAL (View Pletal Review and Pletal Label ), PLAVIX METOPROLOL (View Plavix Metoprolol Review and Plavix Metoprolol Label ).

6131742-8 | Oedema Peripheral
Adverse event was reported on Mar 20, 2009 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: oedema peripheral. During the same period patient was treated with ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ).

6129827-5 | Abasia, Benign Neoplasm Of Spinal Cord, Hypoaesthesia, Sensory Disturbance
on Mar 20, 2009 Male patient from UNITED STATES , 70 years of age, was treated with Tekturna (View Usage). Patient had the following side effects: abasia, benign neoplasm of spinal cord, hypoaesthesia, sensory disturbance. Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with FLOMAX (View Flomax Review and Flomax Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ).

6124075-7 | Arrhythmia, Blood Creatinine Increased, Cardiac Arrest, Cardiac Valve Disease, Cardioversion, Confusional State, Creatinine Renal Clearance Increased, Echocardiogram Abnormal
on Mar 16, 2009 Female patient from UNITED STATES , 72 years of age, weighting 168.0 lb, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?), supraventricular tachycardia and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood creatinine increased, cardiac arrest (What is cardiac arrest?), cardiac valve disease, cardioversion, confusional state, creatinine renal clearance increased, echocardiogram abnormal. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with SOTALOL HYDROCHLORIDE (80 Mg, Bid) (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ), CLONIDINE (0.3 Mg, Bid) (View Clonidine Review and Clonidine Label ), LANTUS (Daily) (View Lantus Review and Lantus Label ), ZOLOFT (50 Mg Daily) (View Zoloft Review and Zoloft Label ), SYNTHROID (25 Ug, Qd) (View Synthroid Review and Synthroid Label ), TOPROL XL (75 Mg Daily) (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6112919-4 | Anxiety, Dysphoria, Irritability
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dysphoria, irritability on Mar 10, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 221.0 lb, was diagnosed with hypertension and. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with SULAR (2 Mg, Qd) (View Sular Review and Sular Label ), CARDURA /IRE/ (2 Mg, Qd) (View Cardura /ire/ Review and Cardura /ire/ Label ).

6091268-7 | Activities Of Daily Living Impaired, Atrial Fibrillation, Blood Pressure Immeasurable, Disturbance In Attention, Extrasystoles, Heart Rate Abnormal, Impaired Work Ability, Loss Of Consciousness, Memory Impairment
Adverse event was reported on Feb 20, 2009 by a Male patient taking Tekturna (View Usage) (Dosage: 1 Tablet Once Daily Po) was diagnosed with hypertension and. Location: UNITED STATES , 52 years of age, weighting 222.0 lb, Patient had the following side effects: activities of daily living impaired, atrial fibrillation (What is atrial fibrillation?), blood pressure immeasurable, disturbance in attention, extrasystoles, heart rate abnormal, impaired work ability, loss of consciousness, memory impairment. Patient was hospitalized and became disabled.

6091187-6 | Renal Failure Acute
on Feb 20, 2009 Female patient from UNITED STATES , 78 years of age, weighting 140.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: renal failure acute. Tekturna dosage: 150 Mg Once Daily Po.

6088156-9 | Anxiety, Dysphoria, Irritability
on Feb 17, 2009 Female patient from UNITED STATES , 69 years of age, weighting 221.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dysphoria, irritability. Tekturna dosage: 300 Mg, Qd.

6057789-8 | Gastroenteritis, Hypertension, Hypovolaemia, Renal Failure Acute
Patient was taking Tekturna (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?), hypertension, hypovolaemia, renal failure acute on Jan 22, 2009 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with hypertension and. Tekturna dosage: Unk. During the same period patient was treated with ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized.

6014769-6 | Abasia, Hypoaesthesia, Sensory Disturbance
Adverse event was reported on Dec 11, 2008 by a Male patient taking Tekturna (View Usage) (Dosage: 150 Mg, Unk) . Location: UNITED STATES , 70 years of age, After Tekturna was administered, patient had the following side effects: abasia, hypoaesthesia, sensory disturbance. During the same period patient was treated with FLOMAX (View Flomax Review and Flomax Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ).

5970975-8 | Abdominal Pain, Dizziness, Endoscopy, Gastritis, Pneumonia Viral
on Nov 20, 2008 Male patient from UNITED STATES , 73 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), endoscopy (What is endoscopy?), gastritis, pneumonia viral. Tekturna dosage: 300 Mg, Qd. During the same period patient was treated with HYTRIN (10 Mg, Qhs) (View Hytrin Review and Hytrin Label ), UROXATRAL (Unk) (View Uroxatral Review and Uroxatral Label ), AMILORIDE HCL AND HYDROCHLOROTHIAZIDE (View Amiloride Hcl And Hydrochlorothiazide Review and Amiloride Hcl And Hydrochlorothiazide Label ), ASPIRIN (81 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5949534-9 | Renal Failure Acute
on Nov 06, 2008 Male patient from UNITED STATES , 50 years of age, was treated with Tekturna (View Usage). Patient had the following side effects: renal failure acute. Tekturna dosage: 300 Mg, Qd.

5940979-X | Abdominal Pain, Dehydration, Diarrhoea, Electrolyte Imbalance, Hypovolaemia, Weight Decreased
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, electrolyte imbalance, hypovolaemia, weight decreased on Oct 28, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 190.4 lb, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Qd. Patient was hospitalized.

5939637-7 | Anxiety, Dysphoria, Irritability
Adverse event was reported on Oct 30, 2008 by a Female patient taking Tekturna (View Usage) (Dosage: 300mg One Daily Po) was diagnosed with hypertension and. Location: UNITED STATES , 69 years of age, weighting 221.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dysphoria, irritability.

5938542-X | Blood Pressure Systolic Increased
on Oct 27, 2008 Male patient from UNITED STATES , weighting 315.3 lb, was treated with Tekturna (View Usage). Patient had the following side effects: blood pressure systolic increased. Tekturna dosage: 150 Mg, Unk. During the same period patient was treated with LOTREL (5/20) (View Lotrel Review and Lotrel Label ), ATENOLOL (100 Mg, Unk) (View Atenolol Review and Atenolol Label ).

5934374-7 | Blood Sodium Decreased, Hyponatraemia, Syncope
on Oct 24, 2008 Female patient from UNITED STATES , weighting 98.98 lb, was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood sodium decreased, hyponatraemia, syncope. Tekturna dosage: 300 Unk, Qd. During the same period patient was treated with LEXXEL (Enal5/felo5, Bid) (View Lexxel Review and Lexxel Label ), ZOCOR (40 Mg, Qd) (View Zocor Review and Zocor Label ), TOPROL XL (50 Mg, Qd) (View Toprol-xl Review and Toprol-xl Label ).

5928272-2 | Oedema
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: oedema on Oct 22, 2008 from UNITED STATES Additional patient health information: Female patient , 91 years of age, . Tekturna dosage: 150mg. Patient was hospitalized.

5926488-2 | Blood Sodium Decreased, Contusion, Convulsion, Dizziness, Hypertension, Inappropriate Antidiuretic Hormone Secretion, Incontinence, Loss Of Consciousness, Raynaud's Phenomenon
Adverse event was reported on Oct 17, 2008 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: UNITED STATES , weighting 105.0 lb, Patient had the following side effects: blood sodium decreased, contusion, convulsion, dizziness (What is dizziness?), hypertension, inappropriate antidiuretic hormone secretion, incontinence, loss of consciousness, raynaud's phenomenon. During the same period patient was treated with PREDNISONE (7.5 Unk, Qd) (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (7.5 Unk, Qw) (View Methotrexate Review and Methotrexate Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL TARTRATE (50 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5924016-9 | Blood Sodium Decreased, Contusion, Convulsion, Dizziness, Hypertension, Inappropriate Antidiuretic Hormone Secretion, Incontinence, Loss Of Consciousness, Raynaud's Phenomenon
on Oct 14, 2008 Female patient from UNITED STATES , weighting 105.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: blood sodium decreased, contusion, convulsion, dizziness (What is dizziness?), hypertension, inappropriate antidiuretic hormone secretion, incontinence, loss of consciousness, raynaud's phenomenon. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with PREDNISONE TAB (7.5 Unk, Qd) (View Prednisone Tab Review and Prednisone Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (7.5 Unk, Qw) (View Methotrexate Review and Methotrexate Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL TARTRATE (50 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5922605-9 | Blood Creatine Phosphokinase Increased, Myalgia
on Oct 13, 2008 Male patient from UNITED STATES , weighting 247.4 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, myalgia. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with ZOCOR (40 Mg, Unk) (View Zocor Review and Zocor Label ), ALLOPURINOL (300 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), METFORMIN HYDROCHLORIDE (500 Mg, Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5922600-X | Renal Failure Acute
Patient was taking Tekturna (View Usage). Patient had the following side effects: renal failure acute on Oct 15, 2008 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with IMDUR (View Imdur Review and Imdur Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), FORADIL /USA/ (View Foradil /usa/ Review and Foradil /usa/ Label ), ZETIA (View Zetia Review and Zetia Label ), SINGULAIR (View Singulair Review and Singulair Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

5919463-5 | Amnesia, Chest Pain, Confusional State, Dysarthria, Swelling, Swelling Face
Adverse event was reported on Oct 09, 2008 by a Female patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) . Location: UNITED STATES , weighting 200.0 lb, After Tekturna was administered, patient had the following side effects: amnesia, chest pain (What is chest pain?), confusional state, dysarthria, swelling, swelling face. During the same period patient was treated with CARDIZEM LA /OLD FORM/ (300 Mg, Qd) (View Cardizem La /old Form/ Review and Cardizem La /old Form/ Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), K DUR (40 Meq, Bid) (View K-dur Review and K-dur Label ), HYDROCHLOROTHIAZIDE (25 Mg, Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NITROSTAT (0.4 Mg, Prn) (View Nitrostat Review and Nitrostat Label ), TRANXENE (7.5 Mg, Qd) (View Tranxene Review and Tranxene Label ), ISOSORBIDE (40 Mg, Bid) (View Isosorbide Review and Isosorbide Label ), DARVOCET N 100 (Unk) (View Darvocet-n 100 Review and Darvocet-n 100 Label ).

5914909-0 | Renal Failure
on Oct 07, 2008 Male patient from UNITED STATES , 87 years of age, was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Tekturna dosage: .

5911963-7 | Chest Discomfort, Dyspnoea, Tongue Oedema
on Sep 30, 2008 Male patient from UNITED STATES , weighting 194.0 lb, was treated with Tekturna (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, tongue oedema. Tekturna dosage: 150 Mg, Once/single. During the same period patient was treated with EXFORGE (5mg Aml, 320 Mg Val, Unk) (View Exforge Review and Exforge Label ), SOTALOL (View Sotalol Review and Sotalol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), RES Q (View Res-q Review and Res-q Label ), YEAST (View Yeast Review and Yeast Label ), NIACIN (View Niacin Review and Niacin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LOVAZA (View Lovaza Review and Lovaza Label ).

5907298-9 | Arrhythmia, Dysphagia, Dyspnoea, Rash, Tachycardia
Patient was taking Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dysphagia, dyspnoea, rash (What is rash?), tachycardia on Sep 30, 2008 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with hypertension and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with PREMARIN (Unk) (View Premarin Review and Premarin Label ).

5906083-1 | Dyspnoea, Swelling
Adverse event was reported on Sep 23, 2008 by a Male patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd) was diagnosed with hypertension and. Location: , 70 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, swelling. Patient was hospitalized.

5904386-8 | Blood Creatinine Increased, Fatigue
on Sep 25, 2008 Male patient from UNITED STATES , 70 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). Patient had the following side effects: blood creatinine increased, fatigue. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), ARB (View Arb Review and Arb Label ), INSULIN (View Insulin Review and Insulin Label ), STATIN (View Statin Review and Statin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5904349-2 | Arrhythmia, Dysphagia, Dyspnoea, Rash, Tachycardia
on Sep 23, 2008 Female patient from UNITED STATES , 80 years of age, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dysphagia, dyspnoea, rash (What is rash?), tachycardia. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with PREMARIN (Unk) (View Premarin Review and Premarin Label ).

5900011-0 | Blood Pressure Inadequately Controlled, Headache, Treatment Failure
Patient was taking Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, headache (What is headache?), treatment failure on Sep 25, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 130.0 lb, was diagnosed with essential hypertension and. Tekturna dosage: 150 Mg Iqd Po.

5898157-9 | Blood Creatinine Increased, Blood Potassium Increased, Blood Pressure Increased, Bradycardia, Headache, Hyperkalaemia, Tinnitus
Adverse event was reported on Aug 31, 2007 by a Male patient taking Tekturna (View Usage) (Dosage: 150 Mg, Qd, Oral) was diagnosed with hypertension and. Location: UNITED STATES , 72 years of age, weighting 233.9 lb, Patient had the following side effects: blood creatinine increased, blood potassium increased, blood pressure increased, bradycardia, headache (What is headache?), hyperkalaemia, tinnitus (What is tinnitus?). During the same period patient was treated with DIOVAN (320 Mg, Qd, Oral) (View Diovan Review and Diovan Label ), ANGIOTENSIN II ANTAGONISTS (NO INGREDIENTS/SUBSTANCES) (View Angiotensin Ii Antagonists (no Ingredients/substances) Review and Angiotensin Ii Antagonists (no Ingredients/substances) Label ), VYTORIN (View Vytorin Review and Vytorin Label ), PRIMIDONE (View Primidone Review and Primidone Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LOPID (View Lopid Review and Lopid Label ).

5895454-8 | Anaphylactic Shock
on Sep 23, 2008 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with hypertension and was treated with Tekturna (View Usage). After Tekturna was administered, patient had the following side effects: anaphylactic shock. Tekturna dosage: 150mg 1 Per Day.

5892666-4 | Blood Sodium Decreased, Hyponatraemia, Syncope
on Sep 16, 2008 Female patient from UNITED STATES , weighting 98.98 lb, was treated with Tekturna (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, hyponatraemia, syncope. Tekturna dosage: 300 Unk, Qd. During the same period patient was treated with LEXXEL (Enal5/felo5, Bid) (View Lexxel Review and Lexxel Label ), ZOCOR (40 Mg, Qd) (View Zocor Review and Zocor Label ), TOPROL XL (50 Mg, Qd) (View Toprol-xl Review and Toprol-xl Label ).

5880292-2 | Blood Creatinine Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Cardiac Failure Congestive, Dyspnoea, Palpitations, Renal Failure Acute
Patient was taking Tekturna (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, brain natriuretic peptide increased, cardiac failure congestive, dyspnoea, palpitations, renal failure acute on Sep 08, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 434.3 lb, was diagnosed with hypertension, oedema, pain (What is pain?) and. Tekturna dosage: 150 Mg, Qd. During the same period patient was treated with GLYBURIDE (2.5 Mg, Qd) (View Glyburide Review and Glyburide Label ), CARTIA XT (360 Mg, Qd) (View Cartia Xt Review and Cartia Xt Label ), TORSEMIDE (20 Mg, Qd) (View Torsemide Review and Torsemide Label ), GLUCOSAMINE SULFATE W/CHONDROITIN (Unk, Unk) (View Glucosamine Sulfate W/chondroitin Review and Glucosamine Sulfate W/chondroitin Label ), MICARDIS (80 Mg, Qd) (View Micardis Review and Micardis Label ), CLONIDINE (1 Mg, Bid) (View Clonidine Review and Clonidine Label ), DARVOCET N 100 (Unk, Prn) (View Darvocet-n 100 Review and Darvocet-n 100 Label ). Patient was hospitalized.